DEXLANSOPRAZOLE DR 30 MG CAP

dexlansoprazole
$4.4485per EA

Strength

30 mg/1

NDC

24979000106

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DEXLANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA202666

On Market Since

12/1/2022

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price History

1W

0.0%

1M

-4.6%

3M

-8.0%

6M

+2.2%

1Y

+0.3%

3Y

-39.6%

5Y

N/A

All

-39.0%